bioRxivNeurosciencePreprint
A p53-ΔNp73 signaling axis drives selective motor neuron degeneration in spinal muscular atrophy
Maria Jose CarliniiD, Xuemei Hu, Leonie Sowoidnich, Archana YadaviD, Jorge GarcíaiD, Maria Savin, Charlotte J. SumneriD, Vilas MenoniD, Christian M. SimoniD, Livio PellizzoniiD
Abstract
Selective neuronal vulnerability is a hallmark of many neurodegenerative diseases, yet how ubiquitous genetic insults cause highly selective neuronal loss remains poorly understood. In spinal muscular atrophy (SMA), reduced SMN levels trigger degeneration of specific motor neuron pools. Although non-apoptotic, p53-mediated death pathways have been implicated, p53 is expressed in both vulnerable and resistant neurons, leaving the downstream determinants of selective vulnerability unresolved. Here, we identify a p53-{Delta}Np73 signaling axis as a previously unrecognized execution pathway driving motor neuron degeneration. Using differential transcriptional profiling of SMA motor neurons following pharmacological modulation of p53 activity, we uncover p73 as a critical downstream mediator of neuronal death. Notably, SMN deficiency induces cell-autonomous, p53-dependent expression of the {Delta}Np73 isoform selectively in vulnerable, but not resistant, motor neurons. {Delta}Np73 induction precisely parallels the spatial and temporal pattern of degeneration in mouse models and is also detected in motor neurons from SMA patients. Strikingly, despite its established role as a pro-survival antagonist of p53, depletion of {Delta}Np73 improves motor neuron survival and partially preserves neuromuscular junction integrity in SMA mice. These findings reveal a context-dependent, isoform-specific functional switch in p53 family signaling that redirects a canonical survival factor into a driver of neurodegeneration, identifying a novel molecular mechanism underlying selective neuronal vulnerability in SMA and a potential therapeutic target for neuroprotection.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuromuscular denervation and deafferentation but not motor neuron death are disease features in the Smn 2B/- mouse model of SMA
Maria Jose Carlini, Marina K Triplett, Livio Pellizzoni·PLoS ONEPeer-reviewed·Aug 1, 2022
- Stasimon contributes to the loss of sensory synapses and motor neuron death in a mouse model of spinal muscular atrophy
Christian M. Simon, Meaghan Van Alstyne, … Livio Pellizzoni·Cell ReportsPeer-reviewed·Jan 1, 2019
- A chemical screen identifies p38 MAPK inhibition as a candidate neuroprotective strategy for combinatorial SMA therapy
Maria Jose Carlini, Jorge Espinoza‐Derout, … Livio Pellizzoni·bioRxiv·Mar 6, 2025
- SMN deficiency induces an early non-atrophic myopathy with alterations in the contractile and excitatory coupling machinery of skeletal myofibers in the SMN{triangleup}7 mouse model of spinal muscular atrophy
Maria Teresa Berciano, Alaó Gatius, … Olga Tapia·International Journal of Molecular SciencesPeer-reviewed·Nov 19, 2024
- Depletion of SMN Protein in Mesenchymal Progenitors Impairs the Development of Bone and Neuromuscular Junction in Spinal Muscular Atrophy
Sang‐Hyeon Hann, Seon-Yong Kim, … Young‐Yun Kong·eLifePeer-reviewed·Nov 7, 2023
- Differential effect of Fas activation on spinal muscular atrophy motoneuron death and induction of axonal growth
Salim Benlefki, Richard Younes, … Cédric Raoul·Cellular and Molecular BiologyPeer-reviewed·Oct 31, 2023